G
Gerhard Zündorf
Researcher at Max Planck Society
Publications - 4
Citations - 1016
Gerhard Zündorf is an academic researcher from Max Planck Society. The author has contributed to research in topics: Alzheimer's disease & Cholinergic neuron. The author has an hindex of 3, co-authored 4 publications receiving 975 citations. Previous affiliations of Gerhard Zündorf include University of Cologne.
Papers
More filters
Journal ArticleDOI
Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET
Karl Herholz,Eric Salmon,Daniela Perani,Jean-Claude Baron,Vjera Holthoff,Lutz Frölich,Peter Schönknecht,Kengo Ito,R. Mielke,Elke Kalbe,Gerhard Zündorf,Xavier Delbeuck,O. Pelati,Davide Anchisi,Ferruccio Fazio,Nacer Kerrouche,Béatrice Desgranges,Francis Eustache,Bettina Beuthien-Baumann,C. Menzel,Johannes Schröder,Takashi Kato,Yutaka Arahata,Marcus Henze,W.-D. Heiss +24 more
TL;DR: A new diagnostic indicator of FDG PET scan abnormality, based on age-adjusted t statistics and an automated voxel-based procedure, is presented and validated in a large data set comprising 110 normal controls and 395 patients with probable Alzheimer's disease (AD) that were studied in eight participating centers as discussed by the authors.
Journal ArticleDOI
In vivo study of acetylcholine esterase in basal forebrain, amygdala, and cortex in mild to moderate Alzheimer disease.
Karl Herholz,Simon Weisenbach,Gerhard Zündorf,Olaf Lenz,Hannsjörg Schröder,Bernd Bauer,Elke Kalbe,Wolf-Dieter Heiss +7 more
TL;DR: The results support the concept that neocortical and amygdaloid functional changes of the cholinergic system are an early and leading event in AD, rather than the consequence of neurodegeneration of basal nuclei.
Journal ArticleDOI
Changes in brain metabolism associated with remission in unipolar major depression.
Vjera Holthoff,Bettina Beuthien-Baumann,Gerhard Zündorf,Antje Triemer,S. Ludecke,Peter Winiecki,Rainer Koch,F. Fuchtner,Karl Herholz +8 more
TL;DR: Functional brain correlates of remission in patients with major depressive disorder are measured with positron emission tomography (PET) and 18F‐fluorodeoxyglucose.